Deerfield Management Company »

Quest Diagnostics Incorporated shares owned by Deerfield Management Company

Quarter-by-quarter ownership of Quest Diagnostics Incorporated (DGX) shares owned by Deerfield Management Company from 13F filings

Historical chart of Deerfield Management Company investment in Quest Diagnostics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Quest Diagnostics Incorporated held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Quest Diagnostics Incorporated by Deerfield Management Company

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.2M 18k 173.53
2024-03-31 $287k 2.2k 133.11
2014-03-31 $26M 440k 57.92

More positions owned by Deerfield Management Company

Nuvalent Inc-a (NUVL)
Brookdale Sr Living Note 3.500%10/1 (Principal)
Cogent Biosciences (COGT)
Praxis Precision Medicines I Com New (PRAX)
Centene Corporation (CNC)
Viatris (VTRS)
Revolution Medicines (RVMD)
United Therapeutics Corporation (UTHR)
Vera Therapeutics Cl A (VERA)
Mirum Pharmaceuticals Note 4.000% 5/0 (Principal)
Celcuity (CELC)
Neurocrine Biosciences (NBIX)
Ionis Pharmaceuticals (IONS)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Inspire Med Sys (INSP)

View all positions for Deerfield Management Company

Top funds holding Quest Diagnostics Incorporated

Vanguard Group
BlackRock
State Street Corporation
Jpmorgan Chase & Co
Robeco Investment Management
Geode Capital Management
Victory Capital Management
Dimensional Fund Advisors
Grantham, Mayo, Van Otterloo & Co
Wells Fargo & Company
Goldman Sachs Group
Invesco
Edgepoint Investment
Davis Selected Advisers
Wellington Management Company

View all funds holding Quest Diagnostics Incorporated